Mymetics Corporation: The First Human Vaccinations of Mymetics' Preventative HIV Vaccine Candidate are Well Tolerated
January 19, 2010 08:00 ET
|
Mymetics Corporation
EPALINGES, Switzerland, Jan. 19, 2010 (GLOBE NEWSWIRE) -- Mymetics Corporation, a pioneer in the development of mucosal focused vaccines for human infectious diseases, announced today that following...
Mymetics Corporation Presents Ground Breaking Results With Preventative HIV Vaccine at the World AIDS Vaccine Congress in Paris 19 - 22 October
October 20, 2009 03:00 ET
|
Mymetics Corporation
EPALINGES, Switzerland, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Mymetics Corporation (OTCBB:MYMX), a pioneer in the development of mucosal focused vaccines for human infectious diseases, announced today...
Mymetics Corporation Announces the Appointment of Dr. Stanley Plotkin as Chairman of the Scientific Advisory Board and Election of New Members
September 09, 2009 08:30 ET
|
Mymetics Corporation
EPALINGES, Switzerland, Sept. 9, 2009 (GLOBE NEWSWIRE) -- Jacques-Francois Martin, newly appointed President and CEO of Mymetics Corporation (www.mymetics.com) (OTCBB:MYMX), announced today the...
Mymetics Corporation's Board of Directors Announces the Appointment of Jacques-Francois Martin as President and CEO
June 26, 2009 12:18 ET
|
Mymetics Corporation
NYON, Switzerland, June 26, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX), today announced that its Board of Directors has named Jacques-Francois Martin as Chairman of...
Mymetics Corporation Completes Important Acquisition
April 09, 2009 12:15 ET
|
Mymetics Corporation
NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics
(www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has
completed the acquisition of Bestewil Holding B.V. and...
Mymetics Corporation Completes Important Acquisition
April 09, 2009 11:38 ET
|
Mymetics Corporation
NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has completed the acquisition of Bestewil Holding B.V. and its...
Mymetics Corporation Acquires Virosome Biologicals B.V.
March 09, 2009 10:14 ET
|
Mymetics Corporation
This Acquisition Advances Mymetics' Corporate Strategy to Expand Its Vaccine
Portfolio and Enhances Mymetics' Implementation of the Virosome Delivery
Technology
NYON, Switzerland, March 9, 2009...
Mymetics Corporation Acquires Virosome Biologicals B.V.
March 09, 2009 09:56 ET
|
Mymetics Corporation
NYON, Switzerland, March 9, 2009 (GLOBE NEWSWIRE) -- Mymetics Corporation (www.mymetics.com) (OTCBB:MYMX) announced today that it has signed a Share Purchase Agreement to acquire 100% of Bestewil...
Press Release
February 09, 2009 13:56 ET
|
Mymetics Corporation
Mymetics Corporation verkündet Erfolg ihres Präventivimpfstoffes gegen HIV/AIDS
und Start der europäischen Phase 1 von menschlichen klinischen Studien
NYON, Schweiz, 6. Feb. 2009 (GLOBE NEWSWIRE)...
Mymetics Corporation Announces Success of Its Preventive Vaccine Against HIV/AIDS and Commencement of European Phase 1 Human Clinical Trials
February 09, 2009 09:00 ET
|
Mymetics Corporation
NYON, Switzerland, Feb. 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX), announced today that on February 11, in Montreal, at the 16th world Conference on Retroviruses...